Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01982760 · ClinicalTrials.gov registry record · Phase 2
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
A Phase 2 study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT01982760 is a Phase 2 study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT01982760, a Phase 2 study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets that promote clotting. In the study, participants who are have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive medication. Photographs taken before and shortly after surgery will be evaluated for the amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not eligible to participate.
Interventions
- DRUG DDAVP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-06-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01982760
The ClinicalTrials.gov registry entry for NCT01982760 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DDAVP is the first listed.
NCT01982760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01982760 about?
NCT01982760 is a clinical study titled "DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty". This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets tha...
What is the current status of trial NCT01982760?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2013-12. Estimated completion is 2015-06-25.
What interventions are being tested in trial NCT01982760?
The interventions under investigation include: DDAVP (DRUG).
Who is sponsoring clinical trial NCT01982760?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.